RecruitingNot ApplicableNCT06867471

Effects of Exogenous Ketosis on Proteinuria and Renal Function

Effects of Exogenous Ketosis on Proteinuria and Renal Function in Patients with Chronic Kidney Disease and Patients with Polycystic Kidney Disease


Sponsor

Gødstrup Hospital

Enrollment

43 participants

Start Date

Sep 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

A randomized, placebo-controlled, double-blinded crossover study will be conducted. Fourteen patients with polycystic kidney disease (PKD) and 29 patients with proteinuric kidney disease will receive ketone bodies (Ketone-IQ) and placebo in a randomized order. Each treatment period is four weeks. There will be a wash-out period of two weeks in between treatment periods. Effect variables will be measured in the last day of each treatment period.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether drinking a ketone supplement can reduce protein leakage in the urine and protect kidney function in people with chronic kidney disease (CKD) or polycystic kidney disease (PKD). **You may be eligible if...** - You have CKD with moderate protein in the urine (ACR between 200–3000 mg/g) and adequate kidney function (eGFR >30), AND you are already on blood pressure medications and SGLT-2 inhibitors; OR - You have polycystic kidney disease (PKD) with adequate kidney function, on similar medications - Women of childbearing age must use reliable contraception **You may NOT be eligible if...** - You are on dialysis or have very low kidney function - You have poorly controlled diabetes or other serious illnesses - You are pregnant or breastfeeding - You are not on the required background medications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTKetone Diol, R-1,3-butanediol (Ketone-IQ)

Effect variables will be measured on the last day of treatment with Ketone-IQ

OTHERPlacebo drink

Effect variables will be measured on the last day of treatment with Placebo


Locations(1)

University Clinic in Nephrology and Hypertension, Gødstrup Region Hospital

Herning, Jutland, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06867471


Related Trials